OncoSenX raises more funds for cancer therapy, plans for clinical trial
GeekWire - 11-May-2020Allowing developments on tech that will kill cancer based on their genetics
Join the club for FREE to access the whole archive and other member benefits.
Late stage pre-clinical cancer company targeting solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.
The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.
Visit website: https://www.oncosenx.com/
See also: Oisin Biotechnologies - Drug development company focused on the senolytic technology to fight age-related diseases
Details last updated 06-Nov-2019
Allowing developments on tech that will kill cancer based on their genetics
When some of these succeed in human trials even more money will pile in to fund further advances
Phase 1 clinical trial starting early 2020